1 Answers
The Drugs for Neglected Diseases initiative is a collaborative, patients' needs-driven, non-profit drug research and development organization that is developing new treatments for neglected diseases, notably leishmaniasis, sleeping sickness , Chagas disease, malaria, filarial diseases, mycetoma, paediatric HIV, and hepatitis C. DNDi's malaria activities were transferred to Medicines for Malaria Venture in 2015.
Led by Executive Director Bernard Pécoul, DNDi is headquartered in Geneva, Switzerland, with offices in Brazil, the Democratic Republic of Congo, India, Japan, Kenya, Malaysia, South Africa, and an affiliate in the United States.
4 views
Answered